Difference between revisions of "About-cancer/treatment/drugs/colorectal"
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Drugs Approved for Colon and Rectal Cancer == | + | == Drugs Approved for Colon and Rectal Cancer == <!--T:1--> |
| + | <!--T:2--> | ||
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for colon and rectal cancer. The list includes generic and brand names. This page also lists common drug combinations used in colon and rectal cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used. | This page lists cancer drugs approved by the Food and Drug Administration (FDA) for colon and rectal cancer. The list includes generic and brand names. This page also lists common drug combinations used in colon and rectal cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used. | ||
| + | <!--T:3--> | ||
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in colon cancer and rectal cancer that are not listed here. | The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in colon cancer and rectal cancer that are not listed here. | ||
| − | === Drugs Approved for Colon Cancer === | + | === Drugs Approved for Colon Cancer === <!--T:4--> |
| + | <!--T:5--> | ||
Avastin (Bevacizumab) | Avastin (Bevacizumab) | ||
| + | <!--T:6--> | ||
Bevacizumab | Bevacizumab | ||
| + | <!--T:7--> | ||
Camptosar (Irinotecan Hydrochloride) | Camptosar (Irinotecan Hydrochloride) | ||
| + | <!--T:8--> | ||
Capecitabine | Capecitabine | ||
| + | <!--T:9--> | ||
Cetuximab | Cetuximab | ||
| + | <!--T:10--> | ||
Cyramza (Ramucirumab) | Cyramza (Ramucirumab) | ||
| + | <!--T:11--> | ||
Eloxatin (Oxaliplatin) | Eloxatin (Oxaliplatin) | ||
| + | <!--T:12--> | ||
Erbitux (Cetuximab) | Erbitux (Cetuximab) | ||
| + | <!--T:13--> | ||
5-FU (Fluorouracil Injection) | 5-FU (Fluorouracil Injection) | ||
| + | <!--T:14--> | ||
Fluorouracil Injection | Fluorouracil Injection | ||
| + | <!--T:15--> | ||
Ipilimumab | Ipilimumab | ||
| + | <!--T:16--> | ||
Irinotecan Hydrochloride | Irinotecan Hydrochloride | ||
| + | <!--T:17--> | ||
Keytruda (Pembrolizumab) | Keytruda (Pembrolizumab) | ||
| + | <!--T:18--> | ||
Leucovorin Calcium | Leucovorin Calcium | ||
| + | <!--T:19--> | ||
Lonsurf (Trifluridine and Tipiracil Hydrochloride) | Lonsurf (Trifluridine and Tipiracil Hydrochloride) | ||
| + | <!--T:20--> | ||
Mvasi (Bevacizumab) | Mvasi (Bevacizumab) | ||
| + | <!--T:21--> | ||
Nivolumab | Nivolumab | ||
| + | <!--T:22--> | ||
Opdivo (Nivolumab) | Opdivo (Nivolumab) | ||
| + | <!--T:23--> | ||
Oxaliplatin | Oxaliplatin | ||
| + | <!--T:24--> | ||
Panitumumab | Panitumumab | ||
| + | <!--T:25--> | ||
Pembrolizumab | Pembrolizumab | ||
| + | <!--T:26--> | ||
Ramucirumab | Ramucirumab | ||
| + | <!--T:27--> | ||
Regorafenib | Regorafenib | ||
| + | <!--T:28--> | ||
Stivarga (Regorafenib) | Stivarga (Regorafenib) | ||
| + | <!--T:29--> | ||
Trifluridine and Tipiracil Hydrochloride | Trifluridine and Tipiracil Hydrochloride | ||
| + | <!--T:30--> | ||
Vectibix (Panitumumab) | Vectibix (Panitumumab) | ||
| + | <!--T:31--> | ||
Xeloda (Capecitabine) | Xeloda (Capecitabine) | ||
| + | <!--T:32--> | ||
Yervoy (Ipilimumab) | Yervoy (Ipilimumab) | ||
| + | <!--T:33--> | ||
Zaltrap (Ziv-Aflibercept) | Zaltrap (Ziv-Aflibercept) | ||
| + | <!--T:34--> | ||
Ziv-Aflibercept | Ziv-Aflibercept | ||
| − | === Drug Combinations Used in Colon Cancer === | + | === Drug Combinations Used in Colon Cancer === <!--T:35--> |
| + | <!--T:36--> | ||
CAPOX | CAPOX | ||
| + | <!--T:37--> | ||
FOLFIRI | FOLFIRI | ||
| + | <!--T:38--> | ||
FOLFIRI-BEVACIZUMAB | FOLFIRI-BEVACIZUMAB | ||
| + | <!--T:39--> | ||
FOLFIRI-CETUXIMAB | FOLFIRI-CETUXIMAB | ||
| + | <!--T:40--> | ||
FOLFOX | FOLFOX | ||
| + | <!--T:41--> | ||
FU-LV | FU-LV | ||
| + | <!--T:42--> | ||
XELIRI | XELIRI | ||
| + | <!--T:43--> | ||
XELOX | XELOX | ||
| − | === Drugs Approved for Rectal Cancer === | + | === Drugs Approved for Rectal Cancer === <!--T:44--> |
| + | <!--T:45--> | ||
Avastin (Bevacizumab) | Avastin (Bevacizumab) | ||
| + | <!--T:46--> | ||
Bevacizumab | Bevacizumab | ||
| + | <!--T:47--> | ||
Camptosar (Irinotecan Hydrochloride) | Camptosar (Irinotecan Hydrochloride) | ||
| + | <!--T:48--> | ||
Capecitabine | Capecitabine | ||
| + | <!--T:49--> | ||
Cetuximab | Cetuximab | ||
| + | <!--T:50--> | ||
Cyramza (Ramucirumab) | Cyramza (Ramucirumab) | ||
| + | <!--T:51--> | ||
Eloxatin (Oxaliplatin) | Eloxatin (Oxaliplatin) | ||
| + | <!--T:52--> | ||
Erbitux (Cetuximab) | Erbitux (Cetuximab) | ||
| + | <!--T:53--> | ||
5-FU (Fluorouracil Injection) | 5-FU (Fluorouracil Injection) | ||
| + | <!--T:54--> | ||
Fluorouracil Injection | Fluorouracil Injection | ||
| + | <!--T:55--> | ||
Ipilimumab | Ipilimumab | ||
| + | <!--T:56--> | ||
Irinotecan Hydrochloride | Irinotecan Hydrochloride | ||
| + | <!--T:57--> | ||
Keytruda (Pembrolizumab) | Keytruda (Pembrolizumab) | ||
| + | <!--T:58--> | ||
Leucovorin Calcium | Leucovorin Calcium | ||
| + | <!--T:59--> | ||
Lonsurf (Trifluridine and Tipiracil Hydrochloride) | Lonsurf (Trifluridine and Tipiracil Hydrochloride) | ||
| + | <!--T:60--> | ||
Mvasi (Bevacizumab) | Mvasi (Bevacizumab) | ||
| + | <!--T:61--> | ||
Nivolumab | Nivolumab | ||
| + | <!--T:62--> | ||
Opdivo (Nivolumab) | Opdivo (Nivolumab) | ||
| + | <!--T:63--> | ||
Oxaliplatin | Oxaliplatin | ||
| + | <!--T:64--> | ||
Panitumumab | Panitumumab | ||
| + | <!--T:65--> | ||
Pembrolizumab | Pembrolizumab | ||
| + | <!--T:66--> | ||
Ramucirumab | Ramucirumab | ||
| + | <!--T:67--> | ||
Regorafenib | Regorafenib | ||
| + | <!--T:68--> | ||
Stivarga (Regorafenib) | Stivarga (Regorafenib) | ||
| + | <!--T:69--> | ||
Trifluridine and Tipiracil Hydrochloride | Trifluridine and Tipiracil Hydrochloride | ||
| + | <!--T:70--> | ||
Vectibix (Panitumumab) | Vectibix (Panitumumab) | ||
| + | <!--T:71--> | ||
Xeloda (Capecitabine) | Xeloda (Capecitabine) | ||
| + | <!--T:72--> | ||
Yervoy (Ipilimumab) | Yervoy (Ipilimumab) | ||
| + | <!--T:73--> | ||
Zaltrap (Ziv-Aflibercept) | Zaltrap (Ziv-Aflibercept) | ||
| + | <!--T:74--> | ||
Ziv-Aflibercept | Ziv-Aflibercept | ||
| − | === Drug Combinations Used in Rectal Cancer === | + | === Drug Combinations Used in Rectal Cancer === <!--T:75--> |
| + | <!--T:76--> | ||
CAPOX | CAPOX | ||
| + | <!--T:77--> | ||
FOLFIRI | FOLFIRI | ||
| + | <!--T:78--> | ||
FOLFIRI-BEVACIZUMAB | FOLFIRI-BEVACIZUMAB | ||
| + | <!--T:79--> | ||
FOLFIRI-CETUXIMAB | FOLFIRI-CETUXIMAB | ||
| + | <!--T:80--> | ||
FOLFOX | FOLFOX | ||
| + | <!--T:81--> | ||
FU-LV | FU-LV | ||
| + | <!--T:82--> | ||
XELIRI | XELIRI | ||
| + | <!--T:83--> | ||
XELOX | XELOX | ||
| − | === Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors === | + | === Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors === <!--T:84--> |
| + | <!--T:85--> | ||
Afinitor (Everolimus) | Afinitor (Everolimus) | ||
| + | <!--T:86--> | ||
Everolimus | Everolimus | ||
| + | <!--T:87--> | ||
Lanreotide Acetate | Lanreotide Acetate | ||
| + | <!--T:88--> | ||
Somatuline Depot (Lanreotide Acetate) | Somatuline Depot (Lanreotide Acetate) | ||
</translate> | </translate> | ||
Latest revision as of 21:18, 29 October 2019
Contents
Drugs Approved for Colon and Rectal Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for colon and rectal cancer. The list includes generic and brand names. This page also lists common drug combinations used in colon and rectal cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in colon cancer and rectal cancer that are not listed here.
Drugs Approved for Colon Cancer
Avastin (Bevacizumab)
Bevacizumab
Camptosar (Irinotecan Hydrochloride)
Capecitabine
Cetuximab
Cyramza (Ramucirumab)
Eloxatin (Oxaliplatin)
Erbitux (Cetuximab)
5-FU (Fluorouracil Injection)
Fluorouracil Injection
Ipilimumab
Irinotecan Hydrochloride
Keytruda (Pembrolizumab)
Leucovorin Calcium
Lonsurf (Trifluridine and Tipiracil Hydrochloride)
Mvasi (Bevacizumab)
Nivolumab
Opdivo (Nivolumab)
Oxaliplatin
Panitumumab
Pembrolizumab
Ramucirumab
Regorafenib
Stivarga (Regorafenib)
Trifluridine and Tipiracil Hydrochloride
Vectibix (Panitumumab)
Xeloda (Capecitabine)
Yervoy (Ipilimumab)
Zaltrap (Ziv-Aflibercept)
Ziv-Aflibercept
Drug Combinations Used in Colon Cancer
CAPOX
FOLFIRI
FOLFIRI-BEVACIZUMAB
FOLFIRI-CETUXIMAB
FOLFOX
FU-LV
XELIRI
XELOX
Drugs Approved for Rectal Cancer
Avastin (Bevacizumab)
Bevacizumab
Camptosar (Irinotecan Hydrochloride)
Capecitabine
Cetuximab
Cyramza (Ramucirumab)
Eloxatin (Oxaliplatin)
Erbitux (Cetuximab)
5-FU (Fluorouracil Injection)
Fluorouracil Injection
Ipilimumab
Irinotecan Hydrochloride
Keytruda (Pembrolizumab)
Leucovorin Calcium
Lonsurf (Trifluridine and Tipiracil Hydrochloride)
Mvasi (Bevacizumab)
Nivolumab
Opdivo (Nivolumab)
Oxaliplatin
Panitumumab
Pembrolizumab
Ramucirumab
Regorafenib
Stivarga (Regorafenib)
Trifluridine and Tipiracil Hydrochloride
Vectibix (Panitumumab)
Xeloda (Capecitabine)
Yervoy (Ipilimumab)
Zaltrap (Ziv-Aflibercept)
Ziv-Aflibercept
Drug Combinations Used in Rectal Cancer
CAPOX
FOLFIRI
FOLFIRI-BEVACIZUMAB
FOLFIRI-CETUXIMAB
FOLFOX
FU-LV
XELIRI
XELOX
Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors
Afinitor (Everolimus)
Everolimus
Lanreotide Acetate
Somatuline Depot (Lanreotide Acetate)
